Biosyntia’s efforts to commercialise a bio-based form of vitamin B7 appear on track after the Danish-based biotech firm closes a €11.5m Series B funding round.
Danish biotech company, Biosyntia, and Munich-based, Wacker Group, are planning to expand production of fermentation-based biotin across Europe and into new markets.
Danish biotech company, Biosyntia and French counterpart, Lantana Bio, have joined forces to step up development of sustainable flavonoids for use in dietary supplements, food and drink fortification, and personal care.
Danish biotech company Biosyntia are to collaborate with French biotech start-up Lantana in a pact that looks to offer natural isoflavonoids at a higher purity and produced in a more cost-effective way.
